Product Information
XIGDUO XR 10 MG-1,000 MG TAB is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $19.2004 per EA under NDC 00310628030. Its NADAC has been published 592 times since Apr 22, 2015.
FDA first approved this application on Oct 29, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 1000 mg/1; mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310628030
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205649FDA Approved
10/29/2014
TE Code
AB
On Market Since
10/29/2014
Pharmacological Classes
Price Statistics
The NADAC for XIGDUO XR 10 MG-1,000 MG TAB has been published 592 times since Apr 22, 2015, and over the history we have for it it has risen 73.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.2004 per EA |
|---|---|
| All-time high | $19.2005 (Aug 12, 2026) |
| All-time low | $11.0530 (Apr 22, 2015) |
| 52-week high | $19.2005 |
| 52-week low | $19.1751 |
| Median price | $16.5373 |
| Average price | $16.2012 |
| Largest weekly change | +9.9% (Jan 18, 2017) |
| Weeks tracked | 592 |
| Tracking since | Apr 22, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of XIGDUO XR 10 MG-1,000 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for XIGDUO XR 10 MG-1,000 MG TAB, manufactured by AstraZeneca Pharmaceuticals LP, is $19.2004 per EA (NDC 00310628030), effective Aug 19, 2026.
How has the price of XIGDUO XR 10 MG-1,000 MG TAB changed over time?
Over the history we have for it, the NADAC for XIGDUO XR 10 MG-1,000 MG TAB has risen 73.7%. It has been tracked across 592 weekly CMS publications since Apr 22, 2015.
What are the highest and lowest recorded NADAC prices for XIGDUO XR 10 MG-1,000 MG TAB?
Since Apr 22, 2015, the NADAC for XIGDUO XR 10 MG-1,000 MG TAB has ranged from a low of $11.0530 (Apr 22, 2015) to a high of $19.2005 (Aug 12, 2026), with a median of $16.5373 per EA.
Are there cheaper alternatives to XIGDUO XR 10 MG-1,000 MG TAB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DAPAGLIFLOZIN-METFORMIN ER 10-1,000 MG TABLET, is $0.7711 per EA — about 96% below XIGDUO XR 10 MG-1,000 MG TAB.
Who manufactures XIGDUO XR 10 MG-1,000 MG TAB?
XIGDUO XR 10 MG-1,000 MG TAB (NDC 00310628030) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.